Paricalcitol as an Antiproteinuric Agent Can Result in the Deterioration of Renal and Heart Function in a Patient with Fabry Disease

Tajda Keber; Martin Tretjak; Andreja Cokan Vujkovac; Marija Mravljak; Katja Ravber; Bojan Vujkovac

doi:10.12659/AJCR.903886

09 June 2017 : Case report Slovenia

Paricalcitol as an Antiproteinuric Agent Can Result in the Deterioration of Renal and Heart Function in a Patient with Fabry Disease

Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Rare disease, Adverse events of drug therapy, Congenital defects / diseases, Clinical situation which can not be reproduced for ethical reasons

Tajda Keber^1ABCDEF*, Martin Tretjak^1BCDEF, Andreja Cokan Vujkovac^1BDEF, Marija Mravljak^1DE, Katja Ravber^1DE, Bojan Vujkovac^1ABCDEFG

DOI: 10.12659/AJCR.903886

Am J Case Rep 2017; 18:644-648

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

Export

Export Article Citation

Share via email

Share method:

Via email client program

Send me to my email

Content:

Title, authors, link

Title, authors, link, abstract

Paricalcitol as an Antiproteinuric Agent Can Result in the Deterioration of Renal and Heart Function in a Patient with Fabry Disease

Export

Export Article Citation

Export file: The selected type of file is required

Content:

Share via email

Share method:

Content:

Preview:

Your Privacy